FDA commissioner talks COVID-19 vaccine development
FDA Commissioner Stephen Hahn spoke with CBS News about how it will handle outside pressure to approve a coronavirus vaccine. Dr. Jon LaPook has more in CBS News' series "Racing to a Cure."
Watch CBS News
FDA Commissioner Stephen Hahn spoke with CBS News about how it will handle outside pressure to approve a coronavirus vaccine. Dr. Jon LaPook has more in CBS News' series "Racing to a Cure."
FDA Commissioner Stephen Hahn suggested on Sunday that he may fast track Phase 3 of a coronavirus vaccine clinical trial, leaving many in the medical community to wonder if he is reacting to pressure from the White House. Clinical professor emeritus at UC Berkeley's School of Public Health and editorial board chair for UC Berkeley Health and Wellness Publications Dr. John Swartzberg told CBSN that truncating the process compromises our ability to know whether a drug is safe or not.
Stephen Hahn, the commissioner of the Food and Drug Administration, told CBS News that outside pressure will not influence the approval of a COVID-19 vaccine. Watch more of his interview on "CBS Evening News" tonight at 6 p.m. ET.
President Trump retweeted a false claim about the number of deaths from the coronavirus pandemic in the U.S. And the head of the FDA said he may consider early approval of a COVID-19 vaccine if the benefits outweigh the risks. Dr. Bob Lahita joined CBSN to break down the latest developments.
"I don't think the FDA commissioner could step in and obviate a decision by the professional staff," Gottlieb said.
Former FDA Commissioner Scott Gottlieb says a widely available vaccine is "really a 2021 event."
The following is a transcript of an interview with former FDA Commissioner Scott Gottlieb that aired Sunday, August 30, 2020, on "Face the Nation."
The new test — which cannot be done at home — uses the same technology used to test for the flu.
Some disinfecting products don't contain enough active ingredients to kill the coronavirus, regulators say.
Students at Florida State University have been arrested and charged with violating COVID-19 regulations by hosting an open house party, and Texas A&M is reporting an outbreak of more than 400 cases. Manuel Bojorquez has more details.
"I can assure the American people that this decision was made based upon sound science and data," Hahn told "CBS This Morning" co-host Gayle King.
AstraZeneca is starting Phase 1 trials of a potential antibody treatment for the coronavirus. Dr. Dyan Hes joins CBSN to discuss that, plus the FDA's controversial move to approve emergency use of convalescent plasma.
FDA Commissioner Dr. Stephen Hahn is defending his administration, saying politics did not play a role in the decision to grant emergency authorization of a possible coronavirus treatment. Only on "CBS This Morning," Hahn responds to charges of politicization of the FDA, and explains how the agency got the data to make the decison.
The FDA has authorized the emergency use of blood plasma for treatment of COVID-19. 70,000 patients in the U.S. have already received the therapy despite scientists warning the effectiveness is still not clear. Dr. Ron Elfenbein joins CBSN to discuss the move.
Several NIH officials last week warned the FDA commissioner against approving the use of convalescent plasma to treat the coronavirus.
Missed the second half of the show? The latest on James Comey's input on the Justice Department handling of the Russia investigation, colleges struggling with COVID-19 surges on campus, and Gottlieb defending the FDA from Trump allegations of political influence.
The Food and Drug Administration announced Sunday that it had authorized an emergency use declaration for convalescent plasma to treat the coronavirus, something President Trump touted as a "historic announcement." Watch his remarks here, along with Secretary of Health and Human Services Alex Azar and FDA commissioner Dr. Stephen Hahn.
The former FDA commissioner says he "firmly reject[s]" allegations that his former agency is slow-walking approvals for COVID treatments.
Mr. Trump claimed Saturday the FDA was slow-walking trials for coronavirus vaccines and therapeutics.
The following is a transcript of an interview with former FDA Commissioner Scott Gottlieb that aired Sunday, August 23, 2020, on "Face the Nation."
The U.S. Food and Drug Administration is looking at a controversial procedure whereby a baby can be created from the DNA of three people. Dr. David Agus, professor of medicine at the University of Southern California, talks about the technique with the "CBS This Morning" co-hosts.
The FDA began two days of meetings about a controversial procedure that removes a mother's nucleus from her egg, leaving behind defective genes, and places it in a donor egg. The procedure aims to prevent children from inheriting diseases, but as Dr. Jon LaPook reports, critics have raised concerns.
Oregon Health & Science University's Dr. Shoukhrat Mitalipov is going before the FDA to seek approval for a new fertilization technique that would create babies from the DNA of three different parents. The controversial method would prevent the passing on of genetic diseases. KOIN's Lisa Balick reports.
Gottlieb said seroprevalence studies show roughly 8% of the U.S. population has been exposed to the coronavirus.
The following is a transcript of an interview with former FDA Commissioner Scott Gottlieb that aired Sunday, August 16, 2020, on "Face the Nation."